During our study of the expression of a Bcl2 mRNA variant in our Ela-mycPT1 mouse pancreatic cancer cell line, we serendipitously obtained a chimeric cDNA that was a fusion between the Bcl2 and the Nek9 genes (Fig 7). This evidence concerns the gene BCL2 and familial pancreatic carcinoma.